PubMed:26200522 JSONTXT

{"project":"wangzhuo19_800","denotations":[{"id":"T1","span":{"begin":14,"end":29},"obj":"CI"},{"id":"T11","span":{"begin":394,"end":397},"obj":"DP"},{"id":"T12","span":{"begin":1272,"end":1275},"obj":"DP"},{"id":"T13","span":{"begin":1236,"end":1240},"obj":"CI"},{"id":"T2","span":{"begin":31,"end":50},"obj":"CI"},{"id":"T3","span":{"begin":55,"end":64},"obj":"CI"},{"id":"T7","span":{"begin":1165,"end":1173},"obj":"CI"},{"id":"T8","span":{"begin":1178,"end":1183},"obj":"CI"},{"id":"T14","span":{"begin":209,"end":231},"obj":"DP"},{"id":"T15","span":{"begin":232,"end":237},"obj":"DP"},{"id":"T16","span":{"begin":268,"end":271},"obj":"DP"},{"id":"T17","span":{"begin":411,"end":426},"obj":"CI"},{"id":"T18","span":{"begin":427,"end":433},"obj":"CI"},{"id":"T19","span":{"begin":472,"end":498},"obj":"CI"},{"id":"T20","span":{"begin":499,"end":509},"obj":"CI"},{"id":"T21","span":{"begin":577,"end":599},"obj":"CI"},{"id":"T22","span":{"begin":600,"end":607},"obj":"CI"}],"text":"Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.\nAIM: The purpose of this study was to compare the effectiveness of different oral iron preparations in children with iron deficiency anemia (IDA).\nMETHODS: Sixty children with IDA, aged between 6 months and 180 months, were randomly assigned into three treatment groups. Group I included children with IDA who received ferrous sulfate (Fe-S); Group II included children receiving iron polymaltose complexes (Fe-OH-PM), and Group III included children receiving a single preparation of combined iron and zinc (Fe-Zn). The effect of different iron preparations were evaluated and compared. The duration of treatment was 8 weeks. Hemoglobin (Hgb) levels, as well as other hematological parameters were determined at admission and the first, fourth, and eighth weeks of the treatment.\nRESULTS: The Hgb levels of patients in all three groups were statistically higher in the fourth (p=0.001) and eighth (p\u003c0.001) weeks compared to baseline; although there was no difference between the groups at the end of the treatment period (p \u003e0.05).\nCONCLUSION: Our results indicate that, Fe-OH-PM and Fe-Zn preparations may also be preferred as a choice like Fe-S for treatment of children with IDA."}

{"project":"chenxin_473849_800_3","denotations":[{"id":"T1","span":{"begin":209,"end":231},"obj":"DP"},{"id":"T10","span":{"begin":1236,"end":1240},"obj":"CI"},{"id":"T11","span":{"begin":472,"end":498},"obj":"CI"},{"id":"T12","span":{"begin":500,"end":508},"obj":"CI"},{"id":"T13","span":{"begin":1165,"end":1173},"obj":"CI"},{"id":"T14","span":{"begin":586,"end":599},"obj":"CI"},{"id":"T15","span":{"begin":601,"end":606},"obj":"CI"},{"id":"T16","span":{"begin":1178,"end":1183},"obj":"CI"},{"id":"T17","span":{"begin":233,"end":236},"obj":"DP"},{"id":"T18","span":{"begin":268,"end":271},"obj":"DP"},{"id":"T19","span":{"begin":394,"end":397},"obj":"DP"},{"id":"T2","span":{"begin":68,"end":90},"obj":"DP"},{"id":"T6","span":{"begin":1272,"end":1275},"obj":"DP"},{"id":"T7","span":{"begin":411,"end":426},"obj":"CI"},{"id":"T8","span":{"begin":14,"end":29},"obj":"CI"},{"id":"T9","span":{"begin":428,"end":432},"obj":"CI"},{"id":"T20","span":{"begin":31,"end":50},"obj":"CI"},{"id":"T21","span":{"begin":55,"end":64},"obj":"CI"}],"text":"Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.\nAIM: The purpose of this study was to compare the effectiveness of different oral iron preparations in children with iron deficiency anemia (IDA).\nMETHODS: Sixty children with IDA, aged between 6 months and 180 months, were randomly assigned into three treatment groups. Group I included children with IDA who received ferrous sulfate (Fe-S); Group II included children receiving iron polymaltose complexes (Fe-OH-PM), and Group III included children receiving a single preparation of combined iron and zinc (Fe-Zn). The effect of different iron preparations were evaluated and compared. The duration of treatment was 8 weeks. Hemoglobin (Hgb) levels, as well as other hematological parameters were determined at admission and the first, fourth, and eighth weeks of the treatment.\nRESULTS: The Hgb levels of patients in all three groups were statistically higher in the fourth (p=0.001) and eighth (p\u003c0.001) weeks compared to baseline; although there was no difference between the groups at the end of the treatment period (p \u003e0.05).\nCONCLUSION: Our results indicate that, Fe-OH-PM and Fe-Zn preparations may also be preferred as a choice like Fe-S for treatment of children with IDA."}

{"project":"yangbin123xm_800_3","denotations":[{"id":"T1","span":{"begin":68,"end":90},"obj":"DP"},{"id":"T10","span":{"begin":1236,"end":1240},"obj":"CI"},{"id":"T11","span":{"begin":55,"end":64},"obj":"CI"},{"id":"T12","span":{"begin":31,"end":50},"obj":"CI"},{"id":"T14","span":{"begin":601,"end":606},"obj":"CI"},{"id":"T15","span":{"begin":1178,"end":1183},"obj":"CI"},{"id":"T16","span":{"begin":500,"end":508},"obj":"CI"},{"id":"T17","span":{"begin":1165,"end":1173},"obj":"CI"},{"id":"T2","span":{"begin":209,"end":231},"obj":"DP"},{"id":"T3","span":{"begin":233,"end":236},"obj":"DP"},{"id":"T4","span":{"begin":268,"end":271},"obj":"DP"},{"id":"T5","span":{"begin":394,"end":397},"obj":"DP"},{"id":"T6","span":{"begin":1272,"end":1275},"obj":"DP"},{"id":"T7","span":{"begin":14,"end":29},"obj":"CI"},{"id":"T8","span":{"begin":411,"end":426},"obj":"CI"},{"id":"T9","span":{"begin":428,"end":432},"obj":"CI"},{"id":"T18","span":{"begin":472,"end":498},"obj":"CI"},{"id":"T19","span":{"begin":586,"end":599},"obj":"CI"}],"text":"Comparison of ferrous sulfate, polymaltose complex and iron-zinc in iron deficiency anemia.\nAIM: The purpose of this study was to compare the effectiveness of different oral iron preparations in children with iron deficiency anemia (IDA).\nMETHODS: Sixty children with IDA, aged between 6 months and 180 months, were randomly assigned into three treatment groups. Group I included children with IDA who received ferrous sulfate (Fe-S); Group II included children receiving iron polymaltose complexes (Fe-OH-PM), and Group III included children receiving a single preparation of combined iron and zinc (Fe-Zn). The effect of different iron preparations were evaluated and compared. The duration of treatment was 8 weeks. Hemoglobin (Hgb) levels, as well as other hematological parameters were determined at admission and the first, fourth, and eighth weeks of the treatment.\nRESULTS: The Hgb levels of patients in all three groups were statistically higher in the fourth (p=0.001) and eighth (p\u003c0.001) weeks compared to baseline; although there was no difference between the groups at the end of the treatment period (p \u003e0.05).\nCONCLUSION: Our results indicate that, Fe-OH-PM and Fe-Zn preparations may also be preferred as a choice like Fe-S for treatment of children with IDA."}